Clinical trial
A Randomized Clinical Trial to Determine the Efficacy of Early Versus Standard Antiretroviral Therapy in HIV Infected Adults With CD4+ T Cell Counts Between 200 and 350 Cells/mm3
NCT00120510 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Clinical Trial to Determine the Efficacy of Early Versus Standard Antiretroviral Therapy in HIV Infected Adults With CD4+ T Cell Counts Between 200 and 350 Cells/mm3
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2007
- Completion date
- September 30, 2009
- Enrollment
- 816 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.